WEIMING WANG: Open Payments
NPI 1821726498 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 48 payments from 4 companies in 2025. Trend: 2023 $1,647 · 2024 $935 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $333 |
| Otsuka America Pharmaceutical, Inc. | 7 | $153 |
| Alkermes, Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
Products named: UZEDY, REXULTI, AUSTEDO XR, ARISTADA, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
